Retinopathy of Prematurity: Clinical Features, Classification, Natural History, Management and Outcome.
作者： Narendran Kalpana , Parag K Shah , Venkatapathy Narendran , Ratnesh Ranjan , Vishma Prabhu
DOI:
关键词: Randomized controlled trial 、 MEDLINE 、 Context (language use) 、 Pediatrics 、 Childhood blindness 、 Gestation 、 Retinopathy of prematurity 、 Medicine 、 Natural history 、 Disease
摘要: CONTEXT Retinopathy of prematurity is an avoidable cause childhood blindness. Proper understanding the classification and treatment methods a must in tackling this disease. EVIDENCE ACQUISITION Literature search with PubMed was conducted covering period 1940-2015 regards to retinopathy prematurity, retrolental fibroplasia, its natural history, treatment. RESULTS The clinical features, screening staging according International (ICROP) has been included illustrations. standard current indications, modalities outcomes from landmark randomized controlled trials on have mentioned. CONCLUSION This review would help pediatricians update their knowledge prematurity. Screening for India, should be performed all preterm neonates who are born <34 weeks gestation and/or <1750 grams birthweight; as well babies 34-36 or 1750-2000 birthweight if they risk factors ROP. start by one month after birth.
参考文章(14)
C. Jandeck, U. Kellner, H. Heimann, M. H. Foerster, Koagulationstherapie bei Frühgeborenenretinopathie Ophthalmologe. ,vol. 102, pp. 33- 38 ,(2005) , 10.1007/S00347-004-1049-6
Ipek Akman, Utku Demirel, Özlem Yenice, Hacer Ilehsoy, Haluk KazokoğLu, Eren Özek, None, Screening criteria for retinopathy of prematurity in developing countries. European Journal of Ophthalmology. ,vol. 20, pp. 931- 937 ,(2010) , 10.1177/112067211002000519
Preliminary results of treatment of eyes with high-risk prethreshold retinopathy of prematurity in the early treatment for retinopathy of prematurity randomized trial. Archives of Ophthalmology. ,vol. 121, pp. 1769- 1771 ,(2003) , 10.1001/ARCHOPHT.121.12.1769
Doyle Lw, Keith Cg, Retinopathy of prematurity in extremely low birth weight infants. Pediatrics. ,vol. 95, pp. 42- 45 ,(1995)
ParagK Shah, V Narendran, KhaledA Tawansy, A Raghuram, Kalpana Narendran, Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity. Indian Journal of Ophthalmology. ,vol. 55, pp. 75- 76 ,(2007) , 10.4103/0301-4738.29505
Wei-Chi Wu, Reyin Lien, Pei-Ju Liao, Nan-Kai Wang, Yen-Po Chen, An-Ning Chao, Kuan-Jen Chen, Tun-Lu Chen, Yih-Shiou Hwang, Chi-Chun Lai, Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity. JAMA Ophthalmology. ,vol. 133, pp. 391- 397 ,(2015) , 10.1001/JAMAOPHTHALMOL.2014.5373
Michael F. Chiang, Raymond R. Arons, John T. Flynn, Justin B. Starren, Incidence of retinopathy of prematurity from 1996 to 2000: Analysis of a comprehensive New York state patient database Ophthalmology. ,vol. 111, pp. 1317- 1325 ,(2004) , 10.1016/J.OPHTHA.2003.10.030
ParagK Shah, V Narendran, SR Sathiamohanraj, D Senthilkumar, N Kalpana, Awareness of retinopathy of prematurity among pediatricians in a tier two city of South India. Oman Journal of Ophthalmology. ,vol. 4, pp. 77- 80 ,(2011) , 10.4103/0974-620X.83658
P K Shah, V Narendran, N Kalpana, K A Tawansy, Anatomical and visual outcome of stages 4 and 5 retinopathy of prematurity Eye. ,vol. 23, pp. 176- 180 ,(2009) , 10.1038/SJ.EYE.6702939
David B. Schaffer, Earl A. Palmer, David F. Plotsky, Henry S. Metz, John T. Flynn, Betty Tung, Robert J. Hardy, Prognostic Factors in the Natural Course of Retinopathy of Prematurity Ophthalmology. ,vol. 100, pp. 230- 237 ,(1993) , 10.1016/S0161-6420(93)31665-9